ObsEva SA
OBSEF
$0.00
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -11.55% | -11.55% | -11.55% | -- | -- |
| Total Other Revenue | -- | -- | -- | -185.16% | -- |
| Total Revenue | -58.40% | -58.40% | -58.40% | 3.64% | -- |
| Cost of Revenue | -80.13% | -80.13% | -80.13% | -- | -- |
| Gross Profit | 128.17% | 128.17% | 128.17% | -- | -- |
| SG&A Expenses | -51.33% | -27.97% | -1.18% | 58.26% | 120.64% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 46.26% | 37.05% | -12.04% | 199.17% | -673.68% |
| Total Operating Expenses | -78.64% | -64.07% | -55.19% | 36.71% | -14.07% |
| Operating Income | 111.06% | 87.53% | 72.31% | 11.14% | 42.06% |
| Income Before Tax | 113.46% | 51.68% | 43.40% | -25.26% | 29.05% |
| Income Tax Expenses | -135.69% | -117.14% | -94.84% | 79.82% | 158.65% |
| Earnings from Continuing Operations | 113.56% | 52.03% | 43.60% | -25.36% | 28.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 113.56% | 52.03% | 43.60% | -25.36% | 28.82% |
| EBIT | 111.06% | 87.53% | 72.31% | 11.14% | 42.06% |
| EBITDA | 111.90% | 88.08% | 72.61% | 10.75% | 42.01% |
| EPS Basic | 109.30% | 48.48% | 43.21% | 2.32% | 47.91% |
| Normalized Basic EPS | 114.18% | 84.99% | 67.54% | 38.76% | 62.08% |
| EPS Diluted | 109.25% | 47.78% | 42.66% | 1.86% | 47.74% |
| Normalized Diluted EPS | 114.18% | 84.99% | 67.54% | 38.76% | 62.08% |
| Average Basic Shares Outstanding | 33.02% | 27.09% | 22.31% | 22.45% | 28.90% |
| Average Diluted Shares Outstanding | 33.02% | 27.09% | 22.31% | 22.45% | 28.90% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |